Identification of Enhancer of Zeste Homolog 2 Expression in Peripheral Circulating Tumor Cells in Metastatic Prostate Cancer Patients: A Preliminary Study

PURPOSE: Enhancer of zeste homolog 2 (EZH2), a kind of transcriptional repressor, is reportedly over-expressed in metastatic prostate cancer. In this study, we analyzed EZH2 mRNA in circulating tumor cells (CTCs) in peripheral blood as a biomarker in patients with metastatic prostate cancer. PATIENT...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Kang Su, Oh, Hea Young, Lee, Eun Jin, Hong, Sung Joon
Formato: Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2007
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628187/
https://www.ncbi.nlm.nih.gov/pubmed/18159594
http://dx.doi.org/10.3349/ymj.2007.48.6.1009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2628187/
https://www.ncbi.nlm.nih.gov/pubmed/18159594
http://dx.doi.org/10.3349/ymj.2007.48.6.1009

Ejemplares similares